PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663550
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663550
Endoscopic Closure Systems Market size was valued at US$ 751.2 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.
A variety of medical equipment known as endoscopic closure systems are intended to seal incisions made during minimally invasive treatments, lowering the risk of problems following surgery. By effectively closing wounds within the body, these products reduce the danger of infection and speed up patient recovery. Among the options are suturing tools that facilitate internal stitching, non-suture closures with clips and staples, and closure-reinforcing sealants and glues. These systems meet the demand for accurate, dependable closure techniques in endoscopy, and the growing number of minimally invasive surgeries, improving technology, and strong emphasis on patient-centred care are the main factors driving preference. Due in large part to the widespread acceptance of minimally invasive procedures, the global market for endoscopic closure systems is experiencing a consistent rate of revenue growth. Since these technologies are essential for reducing overall surgical-related problems, rising surgical volumes are fueling demand for them. The market is becoming more competitive as a result of the ongoing demand for sophisticated closure techniques being driven by advancements in endoscopic technologies. Additionally, initiatives centred on patient outcomes and safety, as well as innovative services and solutions created to address a variety of procedural requirements are propelling the market revenue growth.
Endoscopic Closure Systems Market- Market Dynamics
Rise in the incidence of gastrointestinal disorders
The market for endoscopic closure systems is driven primarily by the rise in the incidence of gastrointestinal disorders. Interestingly, the World Health Organization (WHO) and top medical organizations point to a notable increase in gastrointestinal disorders, including fistulas, leaks, and perforations, which support the rise in desire for less intrusive treatment options. The prevalence of gastrointestinal perforations, for example, is thought to be around 10 per 100,000 people per year, highlighting the urgent need for efficient intervention techniques. Known for being less invasive, endoscopic closure systems present a strong argument since they reduce the dangers involved with conventional surgical treatments and allow for a quicker recovery for patients. Moreover, the global increase in gastrointestinal illnesses, driven by ageing populations and lifestyle-related health issues, further calls for this move towards less invasive therapies. As a result, the market for endoscopic closure systems is expected to rise at a rapid pace as more medical professionals use these cutting-edge tools to treat gastrointestinal conditions more effectively and with better patient outcomes.
Endoscopic Closure Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2025-2032)
Based on application segmentation, the endoscopy was predicted to show maximum market share in the year 2024
Based on product segmentation, the Endoscopic clips/Endoclips (Over-the-scope Clips) was the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Endoscopic Closure Systems Market is segmented on the basis of Application, Product, End Use, and Region.
On the basis of product, the market is segregated into Endoscopic vacuum-assisted closure systems, Endoscopic clips/Endoclips (Over-the-scope Clips), Cardiac septal defect occluders, Overstitch endoscopic suturing systems, and Others. In 2024, the market was dominated by the Endoscopic clips/Endoclips (Over-the-scope Clips) category. These devices are widely used to treat gastrointestinal bleeding and perforations and to secure the implantation of endoluminal devices, which accounts for their importance. Endoscopic clips have become more popular in clinical settings worldwide because of their efficacy, safety, and adaptability. Additionally, ongoing product improvements and innovations targeted at enhancing the accuracy, usability, and success rates of endoscopic treatments are supporting the growth of this market. Since these qualities are crucial for intricate gastrointestinal procedures, manufacturers are concentrating on creating clips with improved flexibility, closure capabilities, and deployment precision.
Based on end use, the market is divided into Hospitals, Ambulatory Surgical Centers (ASC), and Others. In 2024, the hospitals category held a dominant market share. This is due to a number of causes, including the growing popularity of minimally invasive procedures. After all, patients heal more quickly, spend less time in the hospital, and experience less financial pressure. The endoscopic closure systems also grew as a result of hospitals' cooperation and expansion, as well as academic institutions' development of innovative surgical techniques.
Endoscopic Closure Systems Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Endoscopic Closure Systems. This is a result of increased interest in endoscopic closure systems for the treatment of gastrointestinal perforations, as both patients and physicians have recognized the value of these technologies in recent years. Additionally, as the number of endoscopic operations and diagnostic endoscopic procedures increases, so does the demand for endoscopic closure devices. For instance, a 2018 World Gastroenterology Organization investigation revealed that between 18% and 28% of people in North America have GERD, which is expected to fuel market expansion. Furthermore, during the forecast period, a number of factors, such as the existence of state-of-the-art healthcare infrastructure and well-established direct reimbursement policies, would influence market revenue share.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The rising levels of pollution in Asia Pacific nations, particularly China and India, are responsible for the market's expansion in this area. Additionally, endoscopic closure systems are employed in non-invasive or minimally invasive surgical procedures to treat serious illnesses. Asian countries have the highest prevalence of gastrointestinal disorders, such as post-bariatric surgery, cancer, ulcers, per-oral endoscopic myotomy, and others. The WHO Report 2020 ranks Japan as the top country, followed by Korea (27.5 per 100,000) and Mongolia (33.1 per 100,000). The cancer rate in Korea is 39.6 per 100,000. Furthermore, the rising incidence of gastrointestinal illnesses and the high demand for minimally invasive surgical procedures are driving revenue growth throughout the projection period, which in turn is increasing the need for endoscopic closure systems in emerging countries.
The market for endoscopic closure systems is extremely competitive, with numerous domestic and international companies fighting for market share. Medtronic, CONMED Corporation, Olympus Corporation, Teleflex Incorporated, Ethicon (Johnson & Johnson), and others are important market participants. To obtain a competitive edge, these businesses prioritize product innovation, strategic alliances, mergers and acquisitions, and global growth. The competition gets even more fierce as new firms enter the market and offer creative solutions. For instance, in April 2022, Olympus, a world leader in technology for creating and providing cutting-edge solutions for medical and surgical operations, declared that it supports a new Centers for Medicare and Medicaid Services reimbursement. Patients should have easier access to per-oral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) as a result.
Recent Development
January 2024: The acquisition of certain endoscopic vacuum therapy assets, including all reserved rights, from B. Braun Surgical and Aesculap AG will be evaluated by the Administrative Council for Economic Defense (CADE). These businesses are Boston Scientific Corporation's (BSC) indirect subsidiaries.
October 2023: The most recent version of Apollo Endosurgery Inc.'s Apollo ORBIT Endoscopic Vessel Sealing System was unveiled. In both robotic and laparoscopic procedures, this innovative method seeks to increase surgical efficiency and, eventually, improve patient outcomes.
August 2023: When St. Jude Medical Inc. (Abbott) introduced its OccluSaver(R) Heart Hemostasis System to the world, it caused a stir. This innovative endoscopic clip promises to improve patient care in the field by facilitating effective bleeding control during minimally invasive cardiac procedures.